Search Tag: 18F-FES PET/CT

IMAGING Management

2025 12 May

  Accurate assessment of oestrogen receptor (ER) status is critical in guiding endocrine therapy for metastatic breast cancer. Biopsies are commonly used to determine ER status, yet they are susceptible to sampling errors and may not reflect the heterogeneity across lesions. Imaging alternatives such as computed tomography (CT) and 18F-fluorodeoxyglucose...Read more

Women's Health

2025 12 May

  Accurate assessment of oestrogen receptor (ER) status is critical in guiding endocrine therapy for metastatic breast cancer. Biopsies are commonly used to determine ER status, yet they are susceptible to sampling errors and may not reflect the heterogeneity across lesions. Imaging alternatives such as computed tomography (CT) and 18F-fluorodeoxyglucose...Read more

Artificial Intelligence

2025 12 May

  Accurate assessment of oestrogen receptor (ER) status is critical in guiding endocrine therapy for metastatic breast cancer. Biopsies are commonly used to determine ER status, yet they are susceptible to sampling errors and may not reflect the heterogeneity across lesions. Imaging alternatives such as computed tomography (CT) and 18F-fluorodeoxyglucose...Read more